Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)
Improving new radiation therapy techniques for treating liver cancer.
The LARK trial looks at treatment outcomes and treatment efficiency when incorporating our KIM technology with SABR, a new and effective radiation therapy technique that is becoming widely used.
KIM technology provides the radiation therapist with real-time information about the exact location of the tumour. This trial will determine how effectively KIM helps the radiation therapist deliver a more accurate radiation dose. Participants have fiducial markers inserted around their tumours to allow the KIM system to track tumour movement as the patient breathes.
Sites: Westmead Hospital, Nepean Hospital, Princess Alexandra Hospital
Technology: Kilovoltage Intrafraction Monitoring (KIM)
Collaborating Group: TROG Cancer Research
More information: Available at the Australia and New Zealand Clinical Trials Registry here.